y.okonkwo
Submits third-party assay reports on material purchased directly. Based in Salerno.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.76%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041962 | PT-141 (Bremelanotide) | JEEP | JEEP-2603-G6008 | VendorInvestigate | 2026-Q2 | 99.81 | 5.57 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043332 | GHRP-6 | SGN | SGN-2510-P9936 | Janoshik | 2026-Q1 | 98.93 | 1.70 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018952 | PT-141 (Bremelanotide) | FGP | FGP-2505-K9879 | Janoshik | 2025-Q4 | 98.76 | 4.03 | 92.0 | Laboratory-retained | 0 | PASS |
| AX-2025-020143 | Tirzepatide | ERP | ERP-2505-V8880 | Janoshik | 2025-Q4 | 97.01 | 4.47 | 102.7 | Buyer-sourced | 1 | FAIL |
| AX-2025-021008 | Semaglutide | CPC | CPC-2504-G3020 | PeptideMeter | 2025-Q3 | 98.27 | 4.94 | 98.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020423 | Tirzepatide | MKM | MKM-2411-B3660 | Janoshik | 2025-Q2 | 97.75 | 4.20 | 90.4 | Buyer-sourced | 0 | PASS |
| AX-2025-019573 | Humanin (HNG) | Homopeptide | HOMO-2408-A2377 | Medutest | 2025-Q1 | 99.93 | 5.06 | 91.3 | Buyer-sourced | 0 | PASS |
| AX-2024-005099 | PT-141 (Bremelanotide) | MKM | MKM-2404-E3284 | Janoshik | 2024-Q3 | 99.60 | 4.60 | 89.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005532 | Humanin (HNG) | BCH | BCH-2405-D8167 | Medutest | 2024-Q2 | 97.70 | 3.98 | 94.3 | Laboratory-retained | 0 | PASS |